NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

The summary for the NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required): This notice of funding opportunity (NOFO) encourages applications for implementation of investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Support is available for clinical trials up to 5 years, as well as for extended clinical trials of 6- or 7-years.Investigators are encouraged to visit this NIH website for additional information about the overall mission and research areas of NIAID.Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered.

Federal Grant Title:	NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-27-064
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855
CFDA Descriptions:	Information not provided
Current Application Deadline:	July 5th, 2029
Original Application Deadline:	July 5th, 2029
Posted Date:	June 16th, 2026
Creation Date:	June 16th, 2026
Archive Date:	September 5th, 2029
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	June 16th, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact: National Institute of Allergy and Infectious Diseases (NIAID)
[email protected]
[email protected]
Similar Government Grants: • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required); • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required); • Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional); • NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed); • NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (Sen...; • Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed); • Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...; • Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARR...; • Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials N...